Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate novel treatments to delay progression to dementia
in patients with mild cognitive impairment (MCI) and metabolic syndrome (MS). The hypothesis
is that treatment with pioglitazone or endurance exercise training will improve, stabilize,
or attenuate decline in cognitive function compared to controls. This study will also
discover potential mechanisms for the improvements and determine the baseline prevalence of
amnestic versus non-amnestic MCI.